Fabio La Mola is a Partner in L.E.K.’s Singapore office and Global Co-Head of the firm’s Healthcare sector, overseeing the Asia Pacific region and head of the Singapore office. He is also Executive Director of L.E.K.’s Asia-Pacific Life Sciences Centre of Excellence. He has more than 20 years of experience across healthcare services and life sciences, strategy, and organization and performance. Fabio has advised many clients across Southeast Asia, Europe, the Middle East and the U.S. and also serves as an advisor for biotech to the Singapore National Research Foundation (NRF) Central Gap Fund.

Fabio is a talented and dynamic business advisor and leads L.E.K. teams applying analytic techniques and delivering insights for clients to solve complex strategic issues. Fabio has strong experience presenting and building consensus at senior management and board levels, and providing coaching and development support to both clients and members of the firm.

Fabio also works with organizations on strategy development, go-to-market planning, product launches, portfolio optimization, commercial and operating model development, processes, operations and organizational efficiency.

Most recently, Fabio worked on novel business models for pharmaceutical and healthcare, including digital and health tech.


Undergraduate: Business Administration Degree, Bocconi University in Milan

Graduate: Master of Business Administration, Kellogg School of Management

Fabio's Expertise

Read More

Related Insights

Current Trends in ASEAN'S Healthcare Markets

L.E.K. Consulting’s Fabio La Mola shares perspectives on trends, opportunities and winning strategies in ASEAN’s emerging healthcare market.

Webinar Recording: Using Real-World Data to Optimize Pharma Pricing in China

In this webinar, we share perspectives on the application of real-world data in pharma pricing and other sectors within healthcare. 
L.E.K. Consulting’s Fabio La Mola
Healthcare Services

Current Trends in ASEAN'S Healthcare Markets

pharma pricing
Life Sciences & Pharma

Webinar Recording: Using Real-World Data to Optimize Pharma Pricing in China